Performance of bleeding risk scores in dialysis patients

被引:33
|
作者
Ocak, Gurbey [1 ]
Ramspek, Chava [2 ]
Roolunaaker, Maarten B. [1 ]
Blankestijn, Peter J. [1 ]
Verhaar, Marianne C. [1 ]
Bos, Willem Jan W. [3 ]
Dekker, Friedo W. [2 ]
van Diepen, Merel [2 ]
机构
[1] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands
[2] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands
[3] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands
关键词
ATRIA; dialysis; HASBLED; HEMORR2HAGES; ORBIT; HAS-BLED SCORE; ATRIAL-FIBRILLATION; ANTICOAGULATED PATIENTS; HEMODIALYSIS-PATIENTS; CHA(2)DS(2)-VASC SCORES; MULTIPLE IMPUTATION; WARFARIN INITIATION; PREDICTIVE ABILITY; ISCHEMIC-STROKE; HEMORRHAGE;
D O I
10.1093/ndt/gfy387
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background Bleeding risk scores have been created to identify patients with an increased bleeding risk, which could also be useful in dialysis patients. However, the predictive performances of these bleeding risk scores in dialysis patients are unknown. Therefore, the aim of this study was to validate existing bleeding risk scores in dialysis patients. Methods A cohort of 1745 incident dialysis patients was prospectively followed for 3 years during which bleeding events were registered. We evaluated the discriminative performance of the Hypertension, Abnormal kidney and liver function, Stroke, Bleeding, Labile INR, Elderly and Drugs or alcohol (HASBLED), the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA), the Hepatic or kidney disease, Ethanol abuse, Malignancy, Older age, Reduced platelet count or Reduced platelet function, Hypertension, Anaemia, Genetic factors, Excessive fall risk and Stroke (HEMORR2HAGES) and the Outcomes Registry for Better Informed Treatment (ORBIT) bleeding risk scores by calculating C-statistics with 95% confidence intervals (CI). In addition, calibration was evaluated by comparing predicted and observed risks. Results Of the 1745 dialysis patients, 183 patients had a bleeding event, corresponding to an incidence rate of 5.23/100 person-years. The HASBLED [C-statistic of 0.58 (95% CI 0.54-0.62)], ATRIA [C-statistic of 0.55 (95% CI 0.51-0.60)], HEMORR2HAGES [C-statistic of 0.56 (95% CI 0.52-0.61)] and ORBIT [C-statistic of 0.56 (95% CI 0.52-0.61)] risk scores had poor discriminative performances in dialysis patients. Furthermore, the calibration analyses showed that patients with a low risk of bleeding according to the HASBLED, ATRIA, HEMORR2HAGES and ORBIT bleeding risk scores had higher incidence rates for bleeding in our cohort than predicted. Conclusions The HASBLED, ATRIA, HEMORR2HAGES and ORBIT bleeding risk scores had poor predictive abilities in dialysis patients. Therefore, these bleeding risk scores may not be useful in this population.
引用
收藏
页码:1223 / 1231
页数:9
相关论文
共 50 条
  • [31] WARFARIN AND THE RISK OF STROKE AND BLEEDING IN ATRIAL FIBRILLATION PATIENTS UNDERGOING DIALYSIS
    Tsadok, Meytal Avgil
    Jackevicius, Cynthia
    Eisenberg, Mark
    Shah, Mitesh
    Essebag, Vidal
    Rahme, Elham
    Humphries, Karin
    Tu, Jack
    Pilote, Louise
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E340 - E340
  • [32] Treatment of Bleeding in Dialysis Patients
    Galbusera, Miriam
    Remuzzi, Giuseppe
    Boccardo, Paola
    SEMINARS IN DIALYSIS, 2009, 22 (03) : 279 - 286
  • [33] Gastrointestinal bleeding in patients on dialysis
    Mandelbrot, DA
    SEMINARS IN DIALYSIS, 1998, 11 (03) : 161 - 166
  • [34] Modified HASBLED Bleeding Risk Score in Dialysis Patients With Atrial Fibrillation
    Murphy, Michele
    Maddox, William
    Nahman, Stan
    Diamond, Matthew
    Sorrentino, Robert
    Guha, Avirup
    Waller, Jennifer
    CIRCULATION, 2015, 132
  • [35] External validation of the performance of four bleeding risk scores in predicting 30-day major bleeding in pulmonary embolism patients undergoing thrombolysis
    Tao, Yuzhi
    Xi, Linfeng
    Zhang, Yu
    Wang, Dingyi
    Fan, Guohui
    Zhai, Zhenguo
    Wang, Chen
    RESPIROLOGY, 2024, 29 : 59 - 59
  • [36] Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention
    Pelliccia, Francesco
    Gragnano, Felice
    Pasceri, Vincenzo
    Cesaro, Arturo
    Zimarino, Marco
    Calabro, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [37] Performance of risk scores in patients with acute exacerbations of COPD
    Gomes, Lidia
    Pereira, Samuel
    Sousa-Pinto, Bernardo
    Rodrigues, Cidalia
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2023, 49 (05)
  • [38] Comparison of clinical performance of four gastrointestinal bleeding risk scores in Chinese patients with atrial fibrillation receiving oral anticoagulants
    Mei-na Lv
    Xiao-chun Zheng
    Hong-qin Zhang
    Fang-da Xu
    Ting-ting Wu
    Wen-jun Chen
    Xiao-tong Xia
    Jing-lan Fu
    Shao-jun Jiang
    Jin-hua Zhang
    Journal of Thrombosis and Thrombolysis, 2021, 51 : 136 - 142
  • [39] Comparison of clinical performance of four gastrointestinal bleeding risk scores in Chinese patients with atrial fibrillation receiving oral anticoagulants
    Lv, Mei-na
    Zheng, Xiao-chun
    Zhang, Hong-qin
    Xu, Fang-da
    Wu, Ting-ting
    Chen, Wen-jun
    Xia, Xiao-tong
    Fu, Jing-lan
    Jiang, Shao-jun
    Zhang, Jin-hua
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (01) : 136 - 142
  • [40] Validation of Japanese High Bleeding Risk Criteria in Patients Undergoing Percutaneous Coronary Intervention and Comparisons With Contemporary Bleeding Risk Scores
    Shimizu, Takeshi
    Kimishima, Yusuke
    Misaka, Tomofumi
    Yoshihisa, Akiomi
    Yamaki, Takayoshi
    Kunii, Hiroyuki
    Nakazato, Kazuhiko
    Ishida, Takafumi
    Takeishi, Yasuchika
    CIRCULATION, 2021, 144